Triazole derivatives which are SMO antagonists
US7691887B2 · kind B2 · utility
3Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2008 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | May 14, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for the treatment or prevention of conditions which can be ameliorated by Smo antagonism, which method comprises administration to a patient in need thereof of an effective amount of a compound of formula I or a composition comprising a compound of formula I:or a pharmaceutically acceptable salt or solvate thereof; wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.